南昌去正规医院治抑郁要多少钱南昌抑郁症那家好,南昌那个医院能治疗敏感多疑,南昌抑郁症治疗的办法哪个最有效,南昌哪家抑郁焦虑医院最好,南昌失眠专科的医院,南昌市第十二医院治精神科大夫怎么样,南昌哪看幻想

UNITED NATIONS, June 9 (Xinhua) -- China on Thursday called for governments, organizations and individuals to take active actions, enhance solidarity and establish joint prevention and treatment mechanism to deal with AIDS.Yin Li, vice Health minister of China made the remarks as he addressed the United Nations High-Level Meeting on HIV/AIDS held here."As a responsible developing country, the Chinese government has actively fulfilled its commitments in achieving universal access to AIDS prevention and treatment, eliminating social discrimination, and ensuring rights to prevention, treatment and care of people living with HIV/AIDS and their families," he said.Thanks to the efforts over the years, the spread of AIDS epidemic in China has slowed down, the morality rate considerably decreased and life quality of people with HIV/AIDS has significantly improved, Yin added.In order to achieve the goal of zero new HIV infections, zero discrimination and zero AIDS-related deaths defined by the joint UN Program on HIV/AIDS (UNAIDS), China called for all countries, organizations and persons to be mobilized, further enhance solidarity and clearly define responsibilities and establish a joint prevention and treatment mechanism.Yin said that in the face of the common challenge of HIV/AIDS, the developed and developing countries must assume shared responsibilities."The developed countries should further provide developing countries with generous, unconditional financial and technical support. The developing countries should give the same priority to AIDS control as economic development, explore the models of prevention and treatment consistent with their national conditions, " he said.In addition, the private sector and relevant organizations should assume more responsibilities. On one hand, efforts should be made to mobilize more resources in better implementing prevention, treatment and care measures; on the other hand, multinational drug manufactures should reduce drugs and testing equipment prices through technology transfer, contract manufacturing and reduction of monopoly profits in order to provide universal access to treatment services, according to Yin.Yin stressed that the Chinese government would strengthen its working mechanism, enhance coordination across sectors and participation by the entire society, continue to actively participate in global fight against AIDS, assume its responsibilities and obligations so as to make contribution to achieving the goal of global AIDS control.

BERLIN, June 14 (Xinhua) -- A two-year-old boy became the first child to be killed by the deadly E. coli in Germany on Tuesday, officials said.To date, the terrifying EHEC infection has claimed 36 lives in Germany and one in Sweden.The child, from the northern town of Celle, died in hospital in Hanover of kidney failure and abnormal breakdown of red blood cells, two extreme symptoms of the infection with enterohaemorrhagic E. coli (EHEC), authorities in the state of Lower Saxony said.The boy became the youngest known fatal victim since the outbreak of E. coli in May. His father and 10-year-old brother were also infected with the deadly bacteria, but are recovering, doctors told a local newspaper.The Robert Koch Institute, Germany's national disease prevention and control agency, said on Tuesday that a total of 3, 235 cases had been reported in the country. Among them, 782 people are suffering from haemolytic uraemic syndrome (HUS), a life- threatening illness arising from E. coli, which would destroy human kidney and nervous system.The institute added that the number of new infections is declining sharply in recent days, with only seven reported on Tuesday.German authorities announced on Friday that bean sprouts from a farm in northern Germany were one source of the outbreak, and dropped the previous warning against eating raw cucumbers, tomatoes and lettuce. However, the food panic has caused losses worth hundreds of millions of dollars for European farmers.

BEIJING, June 28 (Xinhuanet) -- The figure of adults with diabetes has risen to 347 million worldwide, which is more than doubled in the past three decades, according to a study published in the British journal Lancet.The study, which analyzed data compiled from 2.7 million participants aged 25 and over from across the world, shows approximately 138 million in China have diabetes, and 36 million in the United States.Among high-income countries, diabetes rates were the highest in the U.S., Greenland, Malta, New Zealand, and Spain. The Netherlands, Austria, and France boasted the lowest rates, suggested the study published online by The Lancet journal on June 25.Majid Ezzati, a lead author of the study, said on Reuters: “Diabetes is becoming more common almost everywhere in the world.”Danaei added: “Unless we develop better programs for detecting people with elevated blood sugar and helping them to improve their diet and physical activity and control their weight, diabetes will inevitably continue to impose a major burden on health systems around the world.”

WASHINGTON, June 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Monday unveiled in a report a new strategy to meet the challenges posed by rapidly rising imports of FDA- regulated products and a complex global supply chain.The report, titled "Pathway to Global Product Safety and Quality," calls on the agency to transform the way it conducts business and to act globally in order to promote and protect the health of U.S. consumers.According to the report, the FDA will partner with its counterparts worldwide to create global coalitions of regulators focused on ensuring and improving global product safety and quality. The coalitions of regulators will develop international data information systems and networks, and increase the regular and proactive sharing of data and regulatory resources across world markets.The FDA will build in additional information gathering and analysis capabilities with an increased focus on risk analytics and information technology. It increasingly will leverage the efforts of public and private third parties and industry and allocate FDA resources based on risk."FDA regulated imports have quadrupled since 2000. The FDA and our global regulatory partners recognize this new reality and realize we must work proactively and collaboratively to address the challenges we face," FDA Commissioner Margaret Hamburg said in a statement. "The FDA must further collaborate and leverage in order to close the gap between our import levels and our regulatory resources. This report is an important step in ensuring we are able to fulfill our critical public health mission."

WASHINGTON, June 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Monday unveiled in a report a new strategy to meet the challenges posed by rapidly rising imports of FDA- regulated products and a complex global supply chain.The report, titled "Pathway to Global Product Safety and Quality," calls on the agency to transform the way it conducts business and to act globally in order to promote and protect the health of U.S. consumers.According to the report, the FDA will partner with its counterparts worldwide to create global coalitions of regulators focused on ensuring and improving global product safety and quality. The coalitions of regulators will develop international data information systems and networks, and increase the regular and proactive sharing of data and regulatory resources across world markets.The FDA will build in additional information gathering and analysis capabilities with an increased focus on risk analytics and information technology. It increasingly will leverage the efforts of public and private third parties and industry and allocate FDA resources based on risk."FDA regulated imports have quadrupled since 2000. The FDA and our global regulatory partners recognize this new reality and realize we must work proactively and collaboratively to address the challenges we face," FDA Commissioner Margaret Hamburg said in a statement. "The FDA must further collaborate and leverage in order to close the gap between our import levels and our regulatory resources. This report is an important step in ensuring we are able to fulfill our critical public health mission."